- Home
- RLGT vs OBIO Comparison
RLGT vs OBIO Comparison
Compare RLGT & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RLGT | OBIO |
|---|---|---|
| Founded | 2001 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 408.7M | 362.4M |
| IPO Year | 2006 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RLGT | OBIO |
|---|---|---|
| Price | $8.86 | $5.78 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $11.00 | ★ $12.43 |
| AVG Volume (30 Days) | 136.7K | ★ 320.1K |
| Earning Date | 11-09-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 11.43 | ★ 33.13 |
| EPS | ★ 0.39 | N/A |
| Revenue | ★ $934,356,000.00 | $33,482,000.00 |
| Revenue This Year | $4.96 | N/A |
| Revenue Next Year | $4.98 | $33.03 |
| P/E Ratio | $24.62 | ★ N/A |
| Revenue Growth | 3.51 | ★ 1169.22 |
| 52 Week Low | $5.86 | $3.46 |
| 52 Week High | $10.20 | $6.50 |
Technical Indicators
Market Signals| Indicator | RLGT | OBIO |
|---|---|---|
| Relative Strength Index (RSI) | 47.05 | 48.62 |
| Support Level | $8.14 | $5.54 |
| Resistance Level | $9.05 | $5.98 |
| Average True Range (ATR) | 0.27 | 0.38 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 36.76 | 54.21 |
Price Performance
Historical ComparisonAbout RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services, including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.